Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

A 24-Week, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009186

Enrollment

100

Registered

2024-02-20

Start date

2022-11-17

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Experimental: 300 mg/capsule(proso millet and wheat extract 600 mg/day), Keranat™ capsule will be administered orally twice daily Control : 300 mg/capsule(600 mg/day as placebo)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age 19 and 60 2) Hair gloss score of 3 or less and a hair damage score of less than 18 according to the visual evaluation classification method. 3) Willing to maintain the same hairstyle, hair color, hair length, and hair regimen throughout the study period. 4) Subject must be able to comprehend and voluntarily sign study procedures and consent forms.

Exclusion criteria

Exclusion criteria: 1) Those diagnosed with and receiving treatment for the alopecia within 3months before screening(androgenetic alopecia, alopecia areata, Telogen effluvium, etc.) 2) Use of that may affect hair or hair loss symptoms treatment medicine, dietary supplements, or treatments containing herbal medicine ingredients within 3 months before screening. 3) Any active scalp or skin disease that may interfere with the study treatment and evaluations. 4) Pregnancy or breastfeeding or planning pregnancy 5) Case of abnormal values at creatinine (excess at the upper limit of the reference range) 6) Case of abnormal values at ALT or AST (2 times excess at the upper limit of the reference range)

Design outcomes

Primary

Measure	Time frame
hair gloss; hair elasticity	—

Secondary

Measure	Time frame
Hair health improvement survey;number of hair per unit area;anti-inflammatory Biomaker(IL-1, TNF-a, PGE2);hair thickness;rate of anagen hair;number of hair loss;hair distribution score through clinical photography	—

Countries

Korea, Republic of

Contacts

Public ContactKim Minju

Korean Skin Research Center

mjkim2@koreansrc.com+82-31-712-8520

Outcome results